Mechanisms of autoantibody production in systemic lupus erythematosus

Frontiers in Immunology

Volumn 6, Issue MAY, 2015, Pages

  Han, Shuhong ^a   Zhuang, Haoyang ^a   Shumyak, Stepan ^a   Yang, Lijun ^b   Reeves, Westley H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; B cells; Immune tolerance; Innate immunity; Lupus erythematosus; Systemic; TLR7

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; CELL ANTIGEN; DOUBLE STRANDED DNA; INSULIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; NUCLEIC ACID; PROTEIN KINASE LYN; RIBONUCLEOPROTEIN; THYROGLOBULIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; INNATE IMMUNITY; NONHUMAN; PLASMA CELL; PROTEIN POLYMORPHISM;

EID: 84934274425     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00228     Document Type: Article

References (40)

1. Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev (2015) 14(1):75-9. doi: 10.1016/j.autrev.2014.10.003
2. Giltiay NV, Chappell CP, Clark EA. B-cell selection and the development of autoantibodies. Arthritis Res Ther (2012) 14(Suppl 4):S1. doi:10.1186/ar3918
3. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol (2009) 9(7):491-502. doi:10.1038/nri2572
4. Diamond B, Scharff MD. Somatic mutation of the T15 heavy chain gives rise to antibody with autoantibody specificity. Proc Natl Acad Sci U S A (1984) 81:5841-4. doi:10.1073/pnas.81.18.5841
5. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science (2003) 301(5638):1374-7. doi:10.1126/science.1086907
6. Rhee I, Veillette A. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol (2012) 13(5):439-47. doi:10.1038/ni.2246
7. Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A, et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol (2009) 182(6):3343-7. doi:10.4049/jimmunol.0713370
8. Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, et al. Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood (2012) 119(16):3744-56. doi:10.1182/blood-2011-12-397919
9. Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis MM, Sfikakis PP. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Invest Med (2001) 49(2):157-65. doi:10.2310/6650.2001.34042
10. Lamagna C, Hu Y, DeFranco AL, Lowell CA. B cell-specific loss of Lyn kinase leads to autoimmunity. J Immunol (2014) 192(3):919-28. doi:10.4049/jimmunol.1301979
11. Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol (2011) 32(8):388-94. doi:10.1016/j.it.2011.06.004
12. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity (2004) 20(6):785-98. doi:10.1016/j.immuni.2004.05.010
13. Stohl W, Scholz JL, Cancro MP. Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside. Curr Opin Rheumatol (2011) 23(3):305-10. doi:10.1097/BOR.0b013e328344c15e
14. Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med (2007) 204(8):1959-71. doi:10.1084/jem.20062567
15. Suda T, Suzuki Y, Matsui T, Inoue T, Niide O, Yoshimaru T, et al. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol (2005) 152(5):887-95. doi:10.1111/j.1365-2133.2005.06559.x
16. Fornek JL, Tygrett LT, Waldschmidt TJ, Poli V, Rickert RC, Kansas GS. Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood (2006) 107(3):1085-91. doi:10.1182/blood-2005-07-2871
17. Ettinger R, Sims GP, Robbins R, Withers D, Fischer RT, Grammer AC, et al. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol (2007) 178(5):2872-82. doi:10.4049/jimmunol.178.5.2872
18. Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR, et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc Natl Acad Sci U S A (2012) 109(40):16276-81. doi:10.1073/pnas.1209372109
19. Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum (2004) 50(11):3580-90. doi:10.1002/art.20592
20. Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study. Arthritis Rheum (2012) 64(4):1215-26. doi:10.1002/art.34359
21. Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, Marshall JL, et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J Exp Med (2011) 208(7):1377-88. doi:10.1084/jem.20102065
22. Choi JY, Hsi-enHo J, Pasoto SG, Bunin V, Kim S, Carrasco S, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (2015) 67(4):988-99. doi:10.1002/art.39020
23. Vinuesa CG, Sanz I, Cook MC. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol (2009) 9(12):845-57. doi:10.1038/nri2637
24. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol (2004) 173(9):5361-71. doi:10.4049/jimmunol.173.9.5361
25. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity (2006) 25(3):417-28. doi:10.1016/j.immuni.2006.07.013
26. Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med (2008) 205(13):2995-3006. doi:10.1084/jem.20080462
27. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med (2005) 202(9):1171-7. doi:10.1084/jem.20050630
28. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science (2002) 298(5601):2199-202. doi:10.1126/science.1076071
29. Rawlings DJ, Schwartz MA, Jackson SW, Meyer-Bahlburg A. Integration of B cell responses through toll-like receptors and antigen receptors. Nat Rev Immunol (2012) 12(4):282-94. doi:10.1038/nri3190
30. Hou B, Saudan P, Ott G, Wheeler ML, Ji M, Kuzmich L, et al. Selective utilization of toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity (2011) 34(3):375-84. doi:10.1016/j.immuni.2011.01.011
31. Jegerlehner A, Maurer P, Bessa J, Hinton HJ, Kopf M, Bachmann MF. TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol (2007) 178(4):2415-20. doi:10.4049/jimmunol.178.4.2415
32. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell (2006) 124(4):849-63. doi:10.1016/j.cell.2006.02.019
33. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A (2006) 103(26):9970-5. doi:10.1073/pnas.0603912103
34. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity (2007) 27(5):801-10. doi:10.1016/j.immuni.2007.09.009
35. Fukui R, Saitoh S, Matsumoto F, Kozuka-Hata H, Oyama M, Tabeta K, et al. Unc93B1 biases toll-like receptor responses to nucleic acid in dendritic cells toward DNA-but against RNA-sensing. J Exp Med (2009) 206(6):1339-50. doi:10.1084/jem.20082316
36. Fukui R, Saitoh S, Kanno A, Onji M, Shibata T, Ito A, et al. Unc93B1 restricts systemic lethal inflammation by orchestrating toll-like receptor 7 and 9 trafficking. Immunity (2011) 35(1):69-81. doi:10.1016/j.immuni.2011.05.010
37. Reeves WH, Li Y, Zhuang H. Autoantibodies in systemic lupus erythematosus. 5 ed. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. Philadelphia, PA: Mosby Elsevier (2011). p. 1279-88.
38. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 9(3):379-83. doi:10.1006/jaut.1996.0051
39. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol (2003) 171(6):3296-302. doi:10.4049/jimmunol.171.6.3296
40. Sabbaga J, Line SRP, Potocnjak P, Madaio MP. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol (1989) 19:137-43. doi:10.1002/eji.1830190122